// App-Quantinova.ai

366 : A novel transcript variant of androgen receptor identified in circulating tumor cells from castration-resistant prostate cancer patients as a potentially prognostic biomarker

Researchers

Presenter

  • Zhigang Kang

Principal Investigators

  • Avani Shah

  • Yunkai Yu

  • Paul Meltzer

  • Liang Cao

  • Yuelin Zhu

  • Ali Asgar Bhagat

  • Kyra Zhao

  • Andrew Wu

  • James Gao

  • Ravi Madan

  • James Gulley

  • William Dahut

Medical Centers

  • Clearbridge Biomedics Pte Ltd, Singapore, Singapore

  • National Cancer Institute, Bethesda, MD

  • Clearbridge BioMedics, Bethesda, Singapore

Locations

  • United States

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved